(Q34252383)

31 July 2017

title

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience (English)

1 reference

31 July 2017

0 references

11

Razelle Kurzrock

1 reference

Apostolia Maria Tsimberidou

31 July 2017

2

object named as

Apostolia M Tsimberidou

1 reference

31 July 2017

4

Aung Naing

1 reference

31 July 2017

Jennifer Wheler

1

1 reference

31 July 2017

David Hong

3

1 reference

31 July 2017

Gerald Falchook

5

1 reference

31 July 2017

Sarina Piha-Paul

6

1 reference

31 July 2017

Siqing Fu

7

1 reference

31 July 2017

Stacy Moulder

8

1 reference

31 July 2017

Bettzy Stephen

9

1 reference

31 July 2017

Sijin Wen

10

1 reference

31 July 2017

language of work or name

English

0 references

publication date

27 March 2012

1 reference

31 July 2017

published in

Clinical Cancer Research

1 reference

31 July 2017

volume

18

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

2922-2929

1 reference

Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Nutritional factors and survival of patients with oral cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Toxicity and response criteria of the Eastern Cooperative Oncology Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Race, nutritional status, and survival from breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Prospective validation of a prognostic score to improve patient selection for oncology phase I trials

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Perceptions of cancer patients and their physicians involved in phase I trials

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176886

Prognostic factors among cancer patients with good performance status screened for phase I trials

28 October 2018

1 reference

12 December 2020

Assigning a cause for a particular outcome in oncology: a serious note of caution

1 reference

12 December 2020

Cancer: the road to Amiens

1 reference

12 December 2020

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

1 reference

12 December 2020

Prognostic factors for survival in patients treated in phase I clinical trials

1 reference

12 December 2020

Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience

1 reference

12 December 2020

Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site

1 reference

12 December 2020

90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?

1 reference

12 December 2020

10.1158/1078-0432.CCR-11-2217

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference